Who Owns CRDL?

Cardiol Therapeutics Inc. — Institutional Ownership & 13F Holdings

$1.38

-0.03 (-1.79%)

Market Cap

$109.4M

Shares Outstanding

111,680,087

Institutional Holders

37

Total Inst. Value

$7.4M

% of Float Held

QoQ Holder Change

+11

Institutional data as of Q1 2025

New Positions

9

Closed Positions

8

Increased

12

Decreased

9

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Tejara Capital Ltd$3.1M3,194,990
2AdvisorShares Investments LLC$911K982,488
3MMCAP International Inc. SPC$759K782,625
4UBS Group AG$483K497,857
5PVG ASSET MANAGEMENT CORP$424K437,362
6Lion Street Advisors, LLCNew$318K333,725
7ENVESTNET ASSET MANAGEMENT INC$315K329,149
8Cambridge Investment Research Advisors, Inc.$310K321,285
9Atria Investments, Inc$135K139,053
10MGO ONE SEVEN LLC$97K100,000

Biggest Buyers & Sellers This Quarter

Top Buyers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CRDL?

As of Q1 2025, 37 institutional investors report holding CRDL (Cardiol Therapeutics Inc.) in their 13F filings.

Which hedge fund owns the most CRDL?

The largest institutional holder of CRDL is Tejara Capital Ltd with $3.1M in shares.

Are institutions buying or selling CRDL?

This quarter, 9 institutions opened new positions in CRDL and 8 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.